Structure−Activity Relationship and Solubility Studies of N1‐Substituted Quinoxaline‐2,3‐diones as Kainate Receptor Antagonists
ChemMedChem · 2023
DOI: 10.1002/cmdc.202300278 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Paulina Chałupnik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College in Kraków, 30-688, Kraków, Poland. Hauptthemen laut MEDLINE: Kainic Acid Receptors, Kainic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kainate receptors are a class of ionotropic glutamate receptors that respond to the excitatory neurotransmitter glutamate in the central nervous system and play an important role in the development of neurodegenerative disorders and the regulation of synaptic function. In the current study, we investigated the structure‐ activity relationship of the series of quinoxaline‐2,3‐diones substituted at N1, 6, and 7 positions, as ligands of kainate homomeric receptors GluK1‐3 and GluK5. Pharmacological characterization showed that all derivatives obtained exhibited micromolar affinity at GluK3 receptors with K i values in the range 0.1–4.4 μM range. The antagonistic properties of the selected analogues: N ‐(7‐fluoro‐6‐iodo‐2,3‐dioxo‐3,4‐dihydroquinoxalin‐1(2 H )‐yl)‐3‐sulfamoylbenzamide, N ‐(7‐(1 H ‐imidazol‐1‐yl)‐6‐iodo‐2,3‐dioxo‐3,4‐dihydroquinoxalin‐1(2 H )‐yl)‐3‐sulfamoylbenzamide and N ‐(7‐(1 H ‐imidazol‐1‐yl)‐2,3‐dioxo‐6‐(phenylethynyl)‐3,4‐dihydroquinoxalin‐1(2 H )‐yl)‐3‐sulfamoylbenzamide at GluK3 receptors, were confirmed by an intracellular calcium imaging assay. To correlate in vitro affinity data with structural features of the synthesized compounds and to understand the impact of the substituent in N1 position on ability to form additional protein‐ligand interactions, molecular modeling and docking studies were carried out. Experimental solubility studies using UV spectroscopy detection have shown that 7‐imidazolyl‐6‐iodo analogues with a sulfamoylbenzamide moiety at the N1 position are the best soluble compounds in the series, with molar solubility in TRISS buffer at pH 9 more than 3‐fold higher compared to NBQX, a known AMPA/kainate antagonist.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College in Kraków, 30-688, Kraków, Poland.
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
- Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343, Krakow, Poland.
ORCID-Profile: Paulina Chałupnik, Darryl S Pickering, Tommy N Johansen, Ewa Szymańska
Zitieren
APA
Chałupnik, P., Vialko, A., Pickering, D. S., Nielsen, B., Bay, Y., Skov Kristensen, A., Hinkkanen, M., Szczepańska, K., Karcz, T., Latacz, G., Johansen, T. N., & Szymańska, E. (2023). Structure−Activity Relationship and Solubility Studies of N1‐Substituted Quinoxaline‐2,3‐diones as Kainate Receptor Antagonists. ChemMedChem. https://doi.org/10.1002/cmdc.202300278
Vancouver
Chałupnik P, Vialko A, Pickering DS, Nielsen B, Bay Y, Skov Kristensen A, et al. Structure−Activity Relationship and Solubility Studies of N1‐Substituted Quinoxaline‐2,3‐diones as Kainate Receptor Antagonists. ChemMedChem. 2023. doi:10.1002/cmdc.202300278
BibTeX
@article{Chaupnik2023,
author = {Chałupnik, Paulina and Vialko, Alina and Pickering, Darryl S and Nielsen, Birgitte and Bay, Yasmin and Skov Kristensen, Anders and Hinkkanen, Markus and Szczepańska, Katarzyna and Karcz, Tadeusz and Latacz, Gniewomir and Johansen, Tommy N and Szymańska, Ewa},
title = {Structure−Activity Relationship and Solubility Studies of N1‐Substituted Quinoxaline‐2,3‐diones as Kainate Receptor Antagonists},
journal = {ChemMedChem},
year = {2023},
doi = {10.1002/cmdc.202300278}
}
EUVIMED